Immune Systems

Emerging treatments & clinical trials based on how immune systems affect the development of mesothelioma cell types. Get up to date analysis.

Asia | Biological Therapy | Immune Systems | International | Multi-Modality Therapy | New Drugs | Research | Treatments | Updates

Investigational Drugs May Offer New Ways to Treat Malignant Mesothelioma
ByAlex Strauss May 5, 2016March 16, 2017

There is some exciting news for patients fighting malignant mesothelioma this week. Two new potential mesothelioma drugs, both aimed at…

Read More Investigational Drugs May Offer New Ways to Treat Malignant Mesothelioma
Asbestos | Immune Systems | New Studies | Prevention | Research | Updates

A New Prevention Strategy for Mesothelioma?
ByAlex Strauss March 7, 2016March 16, 2017

Most people who are diagnosed with malignant mesothelioma, whether it’s the pleural or the peritoneal variety, will undergo treatment with…

Read More A New Prevention Strategy for Mesothelioma?
Immune Systems | Immunotherapy | Multi-Modality Therapy | New Drugs | Research | Treatments | Updates

Promising Immunotherapy Drug Fails to Improve Mesothelioma Survival
ByAlex Strauss February 29, 2016March 16, 2017

There is some disappointing news today on the use of the new immunotherapy drug tremelimumab to fight treatment-resistant malignant pleural…

Read More Promising Immunotherapy Drug Fails to Improve Mesothelioma Survival
Canada | Immune Systems | Immunotherapy | International | New Drugs | Research | Treatments | Updates

Mesothelioma Community Hopeful About Newly Approved Immunotherapy Drug
ByAlex Strauss December 6, 2015March 16, 2017

Mesothelioma experts around the world are expressing excitement about the potential of the recently FDA-approved cancer drug Keytruda (pembrolizumab). The latest…

Read More Mesothelioma Community Hopeful About Newly Approved Immunotherapy Drug
Europe | Immune Systems | Immunotherapy | International | Multi-Modality Therapy | New Drugs | Research | Treatments | Updates

Fighting Mesothelioma with Immunotherapy Drug Tremelimumab
ByAlex Strauss November 13, 2015March 16, 2017

A new study on the immunotherapy drug tremelimumab for the treatment of mesothelioma has some good news and some bad…

Read More Fighting Mesothelioma with Immunotherapy Drug Tremelimumab
Biological Therapy | Immune Systems | Immunotherapy | Research | Treatments | Updates | Vaccine

New Immunotherapy for Mesothelioma Relies on Altered T-Cells
ByAlex Strauss October 28, 2015March 16, 2017

An emerging type of mesothelioma therapy that uses altered T-cells to attack tumors is generating some excitement among researchers at…

Read More New Immunotherapy for Mesothelioma Relies on Altered T-Cells
Chemotherapy | Immune Systems | Immunotherapy | Multi-Modality Therapy | New Drugs | New Studies | Research | Treatments | Updates

Promising Early Results from Mesothelioma Vaccine Trial
ByAlex Strauss October 1, 2015March 16, 2017

Researchers studying a new immunotherapy vaccine for mesothelioma have released early findings from an ongoing clinical trial and the results…

Read More Promising Early Results from Mesothelioma Vaccine Trial
Australia | Chemotherapy | Immune Systems | Immunotherapy | International | Mesothelioma | Multi-Modality Therapy | Research | Treatments | Updates

Long Term Mesothelioma Survival with Immune System Activation
ByAlex Strauss September 21, 2015March 16, 2017

A small group of Australian mesothelioma patients have reportedly lived more than twice as long as expected with a combination…

Read More Long Term Mesothelioma Survival with Immune System Activation
Immune Systems | Immunotherapy | Multi-Modality Therapy | New Drugs | New Studies | Research | Treatments | Updates | Virus

Emerging Therapies Target Mesothelioma in New Ways
ByAlex Strauss August 27, 2015March 16, 2017

Targeted therapies may be the future of mesothelioma treatment. That word comes from a team of some of the world’s…

Read More Emerging Therapies Target Mesothelioma in New Ways
Europe | Immune Systems | International | Multi-Modality Therapy | New Drugs | New Studies | Research | Treatments | Updates

Kidney Cancer Drug Slows Mesothelioma Growth in Mice
ByAlex Strauss August 8, 2015March 24, 2019

A drug that has been shown to slow the growth of renal cell carcinoma may have moved a step closer…

Read More Kidney Cancer Drug Slows Mesothelioma Growth in Mice

1 (888) 378-1331

Immune Systems

Investigational Drugs May Offer New Ways to Treat Malignant Mesothelioma

A New Prevention Strategy for Mesothelioma?

Promising Immunotherapy Drug Fails to Improve Mesothelioma Survival

Mesothelioma Community Hopeful About Newly Approved Immunotherapy Drug

Fighting Mesothelioma with Immunotherapy Drug Tremelimumab

New Immunotherapy for Mesothelioma Relies on Altered T-Cells

Promising Early Results from Mesothelioma Vaccine Trial

Long Term Mesothelioma Survival with Immune System Activation

Emerging Therapies Target Mesothelioma in New Ways

Kidney Cancer Drug Slows Mesothelioma Growth in Mice

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES